BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1930 related articles for article (PubMed ID: 16202350)

  • 1. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].
    Swancutt D; Hobbs R; Fitzmaurice D; Mant J; Murray E; Jowett S; Raftery J; Bryan S; Davies M; Lip G
    BMC Cardiovasc Disord; 2004 Jul; 4():12. PubMed ID: 15283871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of systematic screening for the detection of atrial fibrillation.
    Moran PS; Flattery MJ; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009586. PubMed ID: 23633374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
    Rhys GC; Azhar MF; Foster A
    Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic screening for the detection of atrial fibrillation.
    Moran PS; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation Screen, Management, and Guideline-Recommended Therapy in the Rural Primary Care Setting: A Cross-Sectional Study and Cost-Effectiveness Analysis of eHealth Tools to Support All Stages of Screening.
    Orchard J; Li J; Freedman B; Webster R; Salkeld G; Hespe C; Gallagher R; Patel A; Kamel B; Neubeck L; Lowres N
    J Am Heart Assoc; 2020 Sep; 9(18):e017080. PubMed ID: 32865129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.
    Kaasenbrood F; Hollander M; de Bruijn SH; Dolmans CP; Tieleman RG; Hoes AW; Rutten FH
    Br J Gen Pract; 2020 Jun; 70(695):e427-e433. PubMed ID: 31988084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
    Fitzmaurice DA; Hobbs FD; Jowett S; Mant J; Murray ET; Holder R; Raftery JP; Bryan S; Davies M; Lip GY; Allan TF
    BMJ; 2007 Aug; 335(7616):383. PubMed ID: 17673732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K; Shimbo T; Fukui T
    J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Mahon J; Greenhalgh J; Richardson M; Nevitt S; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    PLoS One; 2019; 14(12):e0226671. PubMed ID: 31869370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
    Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
    J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
    Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
    BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.